Log in
Proteovant Therapeutics
Contact
Scott has 23+ years leading drug-hunting chemistry teams, delivering numerous compounds across various disease areas. Previously Director of Discovery Chemistry at BMS.
Links
View in org chart
Drew Fromkin
CEO
Scott Priestley
VP, Discovery Chemistry
Zhihua Sui
Chief Scientific Officer
Helai Mohammad
VP, Biology
Winston Wu
VP, CMC
+ 3 more
Current role
VP, Discovery Chemistry at OnKure Therapeutics
VP, Discovery chemistry at Entos
Co-founder and VP, Discovery Chemistry at Kimia Therapeutics